TEVA
Teva Pharmaceutical Industries Limited American Depositary SharesStock · Health Care$34.81+$0.09 (+0.26%)as of market close, Aug 6, 2026
TEVA — Teva Pharmaceutical Industries Limited American Depositary Shares stock price, chart and key statistics
Key stats
Price data
- Price
- $34.81
- Change YTD
- +11.53%
- Market cap
- 40.6B
- Enterprise value
- 58.5B
- Shares outstanding
- 1.2B
- 52W low
- $15.75
- 52W high
- $37.35
- From 52W high
- -6.80%
- From 52W low
- +121.02%
- 52W range
- 88%
- Beta
- 0.86
Volume
- Rel volume
- 0.54×
- 30D volume
- 5.4M
- 30D $ vol
- 179.6M
Fundamentals
- Sales (ttm)
- 17.3B
- Sales/share
- $14.86
- EPS (ttm)
- $0.60
- FCF (ttm)
- 1.3B
- FCF/share
- $1.16
- Book value/share
- $6.65
- Net margin
- 4.08%
- ROE
- 9.11%
- ROA
- 1.77%
- Debt / equity
- 2.15×
- Current ratio
- 0.88
Growth (CAGR, ttm) · 10Y
- Sales
- -1.20%
- Net income
- -7.43%
- FCF
- -11.34%
- Shares
- +2.89%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -9.98%
- Sales/share
- -3.97%
- FCF/share
- -13.83%
- Book value/share
- -14.50%
- Dividend/share
- n/a
- Price
- -4.33%
- Total return
- -3.93%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 57.7×
- P/OI (ttm)
- 25.3×
- Fwd P/E
- 11.3×
- P/S (ttm)
- 2.3×
- P/B (mrq)
- 5.2×
- P/FCF (ttm)
- 30.1×
- EV/EBITDA (fy)
- 22.6×
- EV/Sales (ttm)
- 3.4×
- FCF yield (ttm)
- 3.32%
- Buyback yield (realized, 1y)
- -1.58%
- Shareholder yield (realized, 1y)
- -1.58%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/E
- 70th
- P/OI
- 72nd
- P/S
- 99th
- P/B
- 100th
- P/FCF
- 76th
Bar = where today's multiple sits in TEVA's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return
1D
+0.26%
1W
-1.69%
1M
+4.72%
3M
-4.21%
YTD
+11.53%
1Y
+121.58%
5Y
+259.24%
Financial statements
Open full TEVA financials →Related Health Care
1MTeva Pharmaceutical Industries Limited American Depositary Shares (TEVA) trades at $34.81 with a live price and an interactive chart covering 44+ years of daily price history, plus key valuation metrics. ChartRow also publishes TEVA's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full TEVA financial statements →
